FDA Approves Imaging Drug That Helps Surgeons Spot Ovarian Cancers

Published on November 29, 2021

Early detection of ovarian cancer helps boost a woman’s survival, and the U.S. Food and Drug Administration on Monday approved a new imaging drug that can help spot tumors during surgery. The drug, Cytalux (pafolacianine), is meant to improve a surgeon’s ability to detect…

Read Full Article (External Site)